Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304960327> ?p ?o ?g. }
- W4304960327 endingPage "167" @default.
- W4304960327 startingPage "153" @default.
- W4304960327 abstract "Tumor angiogenesis is regarded as a promising target for limiting cancer progression because tumor-associated vasculature supplies blood and provides a path for metastasis. Thus, in vitro recapitulation of vascularized tumors is critical to understand the pathology of cancer and identify the mechanisms by which tumor cells proliferate, metastasize, and respond to drugs. In this study, we microengineered a vascularized tumor spheroid (VTS) model to reproduce the pathological features of solid tumors. We first generated tumor-EC hybrid spheroids with self-assembled intratumoral vessels, which enhanced the uniformity of the spheroids and peritumoral angiogenic capacity compared to spheroids composed only with cancer cells. Notably, the hybrid spheroids also exhibited expression profiles associated with aggressive behavior. The blood vessels sprouting around the hybrid spheroids on the VTS chip displayed the distinctive characteristics of leaky tumor vessels. With the VTS chip showing a progressive tumor phenotype, we validated the suppressive effects of axitinib on tumor growth and angiogenesis, which depended on exposure dose and time, highlighting the significance of tumor vascularization to predict the efficacy of anticancer drugs. Ultimately, we effectively induced both lymphangiogenesis and angiogenesis around the tumor spheroid by promoting interstitial flow. Thus, our VTS model is a valuable platform with which to investigate the interactions between tumor microenvironments and explore therapeutic strategies in cancer. STATEMENT OF SIGNIFICANCE: We conducted an integrative study within a vascularized tumor spheroid (VTS) model. We first generated tumor-EC hybrid spheroids with self-assembled intratumoral vessels, which enhanced the uniformity of the spheroids and peritumoral angiogenic capacity compared to spheroids composed only with cancer cells. Through RNA sequencing, we elucidated that the tumor-EC hybrid spheroids exhibited expression profiles associated with aggressive behavior such as cancer progression, invasion and metastasis. The blood vessels sprouting around the hybrid spheroids on the VTS chip displayed the distinctive characteristics of leaky tumor vessels. We further validated the suppressive effects of axitinib on tumor growth and angiogenesis, depending on exposure dose and time. Ultimately, we effectively induced both lymphangiogenesis and angiogenesis around the tumor spheroid by promoting interstitial flow." @default.
- W4304960327 created "2022-10-14" @default.
- W4304960327 creator A5000113107 @default.
- W4304960327 creator A5014774941 @default.
- W4304960327 creator A5017879313 @default.
- W4304960327 creator A5022375299 @default.
- W4304960327 creator A5028392157 @default.
- W4304960327 creator A5030453441 @default.
- W4304960327 creator A5040256311 @default.
- W4304960327 creator A5048958395 @default.
- W4304960327 creator A5051796736 @default.
- W4304960327 creator A5062946783 @default.
- W4304960327 creator A5069869461 @default.
- W4304960327 creator A5076907616 @default.
- W4304960327 creator A5086035404 @default.
- W4304960327 creator A5086188006 @default.
- W4304960327 date "2023-07-01" @default.
- W4304960327 modified "2023-10-15" @default.
- W4304960327 title "3D microengineered vascularized tumor spheroids for drug delivery and efficacy testing" @default.
- W4304960327 cites W1971747822 @default.
- W4304960327 cites W2010487285 @default.
- W4304960327 cites W2025036947 @default.
- W4304960327 cites W2029400929 @default.
- W4304960327 cites W2037707039 @default.
- W4304960327 cites W2041585886 @default.
- W4304960327 cites W2043249221 @default.
- W4304960327 cites W2044228465 @default.
- W4304960327 cites W2067958384 @default.
- W4304960327 cites W2079083095 @default.
- W4304960327 cites W2081560083 @default.
- W4304960327 cites W2084304481 @default.
- W4304960327 cites W2088004044 @default.
- W4304960327 cites W2098600061 @default.
- W4304960327 cites W2106932520 @default.
- W4304960327 cites W2115307546 @default.
- W4304960327 cites W2117692326 @default.
- W4304960327 cites W2127787683 @default.
- W4304960327 cites W2130234889 @default.
- W4304960327 cites W2136445803 @default.
- W4304960327 cites W2206057428 @default.
- W4304960327 cites W2257467030 @default.
- W4304960327 cites W2332155194 @default.
- W4304960327 cites W2407812106 @default.
- W4304960327 cites W2460593466 @default.
- W4304960327 cites W2510834891 @default.
- W4304960327 cites W2591628935 @default.
- W4304960327 cites W2620210433 @default.
- W4304960327 cites W2695955856 @default.
- W4304960327 cites W2736644389 @default.
- W4304960327 cites W2753794398 @default.
- W4304960327 cites W2768063809 @default.
- W4304960327 cites W2774876944 @default.
- W4304960327 cites W2792184976 @default.
- W4304960327 cites W2795989070 @default.
- W4304960327 cites W2804842145 @default.
- W4304960327 cites W2810490048 @default.
- W4304960327 cites W2810716677 @default.
- W4304960327 cites W2903694002 @default.
- W4304960327 cites W2921139978 @default.
- W4304960327 cites W2922394097 @default.
- W4304960327 cites W2959225239 @default.
- W4304960327 cites W2965583117 @default.
- W4304960327 cites W2972802464 @default.
- W4304960327 cites W2981018318 @default.
- W4304960327 cites W3012803037 @default.
- W4304960327 cites W3106035297 @default.
- W4304960327 cites W3109599094 @default.
- W4304960327 cites W3127400878 @default.
- W4304960327 cites W3176360083 @default.
- W4304960327 cites W4212929031 @default.
- W4304960327 cites W4214834022 @default.
- W4304960327 cites W4220927318 @default.
- W4304960327 doi "https://doi.org/10.1016/j.actbio.2022.10.009" @default.
- W4304960327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36243378" @default.
- W4304960327 hasPublicationYear "2023" @default.
- W4304960327 type Work @default.
- W4304960327 citedByCount "5" @default.
- W4304960327 countsByYear W43049603272023 @default.
- W4304960327 crossrefType "journal-article" @default.
- W4304960327 hasAuthorship W4304960327A5000113107 @default.
- W4304960327 hasAuthorship W4304960327A5014774941 @default.
- W4304960327 hasAuthorship W4304960327A5017879313 @default.
- W4304960327 hasAuthorship W4304960327A5022375299 @default.
- W4304960327 hasAuthorship W4304960327A5028392157 @default.
- W4304960327 hasAuthorship W4304960327A5030453441 @default.
- W4304960327 hasAuthorship W4304960327A5040256311 @default.
- W4304960327 hasAuthorship W4304960327A5048958395 @default.
- W4304960327 hasAuthorship W4304960327A5051796736 @default.
- W4304960327 hasAuthorship W4304960327A5062946783 @default.
- W4304960327 hasAuthorship W4304960327A5069869461 @default.
- W4304960327 hasAuthorship W4304960327A5076907616 @default.
- W4304960327 hasAuthorship W4304960327A5086035404 @default.
- W4304960327 hasAuthorship W4304960327A5086188006 @default.
- W4304960327 hasConcept C121608353 @default.
- W4304960327 hasConcept C126322002 @default.
- W4304960327 hasConcept C142724271 @default.
- W4304960327 hasConcept C175369904 @default.
- W4304960327 hasConcept C185592680 @default.